From the School of Public Health, Kaohsiung Medical College, Kaohsiung,
Taiwan, Republic of China.
Correspondence to Chun-Yuh Yang, School of Public Health, Kaohsiung Medical College, 100 Shih-Chuan 1st RD, Kaohsiung 80708, Taiwan, ROC. E-mail chunyuh{at}cc.kmc.edu.tw
Background and PurposeMany studies
have demonstrated a negative association between mortality from
cardiovascular or cerebrovascular diseases and water
hardness. This report examines whether calcium and magnesium in
drinking water are protective against cerebrovascular disease.
MethodsAll eligible cerebrovascular deaths (17 133 cases) of
Taiwan residents from 1989 through 1993 were compared with deaths from
other causes (17 133 controls), and the levels of calcium and
magnesium in drinking water of these residents were determined. Data on
calcium and magnesium levels in drinking water throughout Taiwan were
obtained from the Taiwan Water Supply Corporation. The control group
consisted of people who died from other causes, and the controls were
pair matched to the cases by sex, year of birth, and year of death.
ResultsThe adjusted odds ratios (95% confidence interval) were
0.75 (0.65 to 0.85) for the group with water magnesium levels between
7.4 and 13.4 mg/L and 0.60 (0.52 to 0.70) for the group with magnesium
levels of 13.5 mg/L or more. After adjustment for magnesium levels in
drinking water, there was no difference between the groups with
different levels of calcium.
ConclusionsThe results of the present study show that there
is a significant protective effect of magnesium intake from drinking
water on the risk of cerebrovascular disease. This is an important
finding for the Taiwan water industry and human health.
© 1998 American Heart Association, Inc.
Original Contributions
Calcium and Magnesium in Drinking Water and Risk of Death From Cerebrovascular Disease
Key Words: calcium cerebrovascular disorders magnesium mortality
This article has been cited by other articles:
![]() |
W.-H. Chen, C.-C. Lui, C.-J. Chen, and J.-S. Liu An Increase of Anticardiolipin Antibody in Association with Stroke and Chronic Chemical Exposure Clinical and Applied Thrombosis/Hemostasis, April 1, 2006; 12(2): 231 - 235. [Abstract] [PDF] |
||||
![]() |
J. Amighi, S. Sabeti, O. Schlager, W. Mlekusch, M. Exner, W. Lalouschek, R. Ahmadi, E. Minar, and M. Schillinger Low Serum Magnesium Predicts Neurological Events in Patients With Advanced Atherosclerosis Stroke, January 1, 2004; 35(1): 22 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Uetani, T. Matsubara, H. Nomura, T. Murohara, and S. Nakayama Ca2+-dependent Modulation of Intracellular Mg2+ Concentration with Amiloride and KB-R7943 in Pig Carotid Artery J. Biol. Chem., November 28, 2003; 278(48): 47491 - 47497. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |